MiR-200c sensitizes clear-cell renal cell carcinoma cells to sorafenib and imatinib by targeting heme oxygenase-1
Chong Gao(The Graduate Center, CUNY), L. K. PENG(Central South University)
Cited by 64
Related Papers
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
|Breast Cancer Research|2019|49